NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | 0.0% | 2,900 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | -50.0% | 2,900 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | -66.7% | 2,900 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $6 | -100.0% | 2,900 | -93.7% | 0.00% | 0.0% |
| Q3 2022 | $16,000 | -33.3% | 46,200 | -29.1% | 0.00% | -50.0% |
| Q2 2022 | $24,000 | -80.5% | 65,200 | -63.9% | 0.00% | -71.4% |
| Q1 2022 | $123,000 | -7.5% | 180,817 | +1095.2% | 0.01% | +40.0% |
| Q4 2021 | $133,000 | +19.8% | 15,128 | +144.0% | 0.01% | 0.0% |
| Q3 2021 | $111,000 | +4.7% | 6,200 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $106,000 | -14.5% | 6,200 | 0.0% | 0.01% | -16.7% |
| Q1 2021 | $124,000 | +359.3% | 6,200 | +195.2% | 0.01% | +500.0% |
| Q4 2020 | $27,000 | +3.8% | 2,100 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $26,000 | -29.7% | 2,100 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $37,000 | -54.9% | 2,100 | -84.4% | 0.00% | -50.0% |
| Q1 2020 | $82,000 | +1266.7% | 13,500 | +513.6% | 0.00% | – |
| Q4 2019 | $6,000 | -66.7% | 2,200 | -24.1% | 0.00% | -100.0% |
| Q3 2019 | $18,000 | -56.1% | 2,900 | -3.3% | 0.00% | -50.0% |
| Q2 2019 | $41,000 | -21.2% | 3,000 | -18.9% | 0.00% | -20.0% |
| Q1 2019 | $52,000 | +48.6% | 3,700 | -72.4% | 0.01% | +66.7% |
| Q4 2018 | $35,000 | -93.6% | 13,383 | -50.6% | 0.00% | -91.9% |
| Q3 2018 | $543,000 | -40.7% | 27,083 | -58.8% | 0.04% | -49.3% |
| Q2 2018 | $916,000 | -63.3% | 65,683 | +72.0% | 0.07% | -65.9% |
| Q1 2018 | $2,498,000 | +234.9% | 38,183 | -16.2% | 0.21% | +613.3% |
| Q4 2017 | $746,000 | +1123.0% | 45,540 | +56.1% | 0.03% | +900.0% |
| Q3 2017 | $61,000 | -11.6% | 29,182 | -6.2% | 0.00% | 0.0% |
| Q2 2017 | $69,000 | -53.4% | 31,100 | -44.7% | 0.00% | -50.0% |
| Q1 2017 | $148,000 | +35.8% | 56,200 | +113.8% | 0.01% | +100.0% |
| Q4 2016 | $109,000 | +29.8% | 26,282 | +213.6% | 0.00% | -25.0% |
| Q3 2016 | $84,000 | +147.1% | 8,382 | -27.6% | 0.00% | +300.0% |
| Q2 2016 | $34,000 | +161.5% | 11,582 | -37.7% | 0.00% | 0.0% |
| Q1 2016 | $13,000 | -93.0% | 18,582 | -41.4% | 0.00% | -90.0% |
| Q4 2015 | $187,000 | – | 31,684 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 508,000 | $6,132,000 | 1.80% |
| Bodri Capital Management, LLC | 250,000 | $3,018,000 | 1.46% |
| Granahan Investment Management | 3,442,980 | $41,557,000 | 1.28% |
| TIRSCHWELL & LOEWY INC | 603,441 | $7,284,000 | 1.22% |
| NEA Management Company, LLC | 1,825,600 | $22,035,000 | 1.12% |
| Cormorant Asset Management, LP | 450,000 | $5,432,000 | 1.12% |
| HARVEY CAPITAL MANAGEMENT INC | 221,750 | $2,676,000 | 1.05% |
| Cheyne Capital Management (UK) LLP | 229,577 | $2,772,000 | 0.99% |
| Artal Group S.A. | 1,650,000 | $19,916,000 | 0.73% |
| FIC CAPITAL INC | 147,293 | $1,778,000 | 0.71% |